Trending...
- Paul Ohana - From Beverly Hills Salon Chair To Beauty Founder Celebrity Hair Expert
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A!
RICHMOND, Calif. - illiNews -- DeepThink Health, Inc., a technology innovator in advanced analytics and artificial intelligence for precision medicine, announced today that Intermountain Healthcare is strengthening its cross-organizational Molecular Tumor Board with the adoption of DeepThink's Precision Tumor Board Solution.
The Precision Tumor Board Solution from DeepThink delivers a streamlined workflow and collaborative learning system that supports multi-organizational and national tumor boards and enables multi-disciplinary clinicians to participate synchronously or asynchronously, in-person or remotely, and via web or mobile applications. With DeepThink's smart search and cohort analytics, clinicians can compare a specific patient to similar patients and analyze their outcome and prognosis within the institution or across broader evidence sharing networks. The solution enables evidence-based decision making for molecular testing, therapy selection, and clinical trial matching. It provides quality and compliance reporting, as well as outcome analytics to monitor consistency in care and value-based performance.
More on illi News
"We are excited to partner with DeepThink as we continue to advance our efforts in precision medicine." said Lincoln D. Nadauld, MD, Vice President of Precision Health for Intermountain Healthcare. "DeepThink's solutions enhance our ability to scale precision medicine practice by simplifying access to complex health data, liberating key insights from real-world data, and supporting tumor board management with real-time access for clinicians."
"We're pleased to be expanding our working relationship with Intermountain Healthcare, one of the world's leading precision medicine programs," said David C. Dvorak, Chairman and Chief Executive Officer of DeepThink Health. "Because cancer is driven by genetic change, sophisticated solutions are needed at the point of care in order to incorporate clinical and molecular insights into patient treatment decisions. Through this multi-year arrangement, Intermountain is deploying the DeepThink technology that is specifically designed to address this need. We look forward to working closely with Intermountain as we strive to bring the full promise of precision medicine to the treatment of patients."
For more information visit www.deepthinkhealth.com
The Precision Tumor Board Solution from DeepThink delivers a streamlined workflow and collaborative learning system that supports multi-organizational and national tumor boards and enables multi-disciplinary clinicians to participate synchronously or asynchronously, in-person or remotely, and via web or mobile applications. With DeepThink's smart search and cohort analytics, clinicians can compare a specific patient to similar patients and analyze their outcome and prognosis within the institution or across broader evidence sharing networks. The solution enables evidence-based decision making for molecular testing, therapy selection, and clinical trial matching. It provides quality and compliance reporting, as well as outcome analytics to monitor consistency in care and value-based performance.
More on illi News
- CodeAutomation Expands U.S. Footprint to Meet Growing Demand for AI and Automation Solutions
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
"We are excited to partner with DeepThink as we continue to advance our efforts in precision medicine." said Lincoln D. Nadauld, MD, Vice President of Precision Health for Intermountain Healthcare. "DeepThink's solutions enhance our ability to scale precision medicine practice by simplifying access to complex health data, liberating key insights from real-world data, and supporting tumor board management with real-time access for clinicians."
"We're pleased to be expanding our working relationship with Intermountain Healthcare, one of the world's leading precision medicine programs," said David C. Dvorak, Chairman and Chief Executive Officer of DeepThink Health. "Because cancer is driven by genetic change, sophisticated solutions are needed at the point of care in order to incorporate clinical and molecular insights into patient treatment decisions. Through this multi-year arrangement, Intermountain is deploying the DeepThink technology that is specifically designed to address this need. We look forward to working closely with Intermountain as we strive to bring the full promise of precision medicine to the treatment of patients."
For more information visit www.deepthinkhealth.com
Source: DeepThink Health
0 Comments
Latest on illi News
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- Chicago: Mayor Brandon Johnson, R2 Development Celebrate Grand Opening of The Bellwether, First Completed Office to Residential Conversion in The Loop
- Chicago: Mayor Brandon Johnson, DFSS Launch Disaster Relief Assistance Program for People Who Faced Financial Hardship Due to Severe Storms in 2023 and 2024
- Mayor Brandon Johnson, City Officials, and Community Leaders Outline Plans For Chicago's 2026 Mexican Independence Day Celebrations
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Howe & Hutton Closes; Jonathan T. Howe Transitions to Association Law Group LLC
- Naperville: Police Investigate Report of Gunshots
- Aerostratospheric Adds xAirship and Other Shop Test Units to Its xPrototypes Bench
- Firebox Encapsulator Introduces a New Approach to Fireplace Restoration
- Merlin's Pet Therapy Wrap Introduces a Versatile Approach to Hot and Cold Therapy for Dogs
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Patented NogginLOC Technology Offers an Innovative Approach to Helmet Fastening
- Mandeville Pests May Pose Serious Health Risks for Your Family
- City of Chicago Partners With Chicago River Swim to Re-Launch "The Big Jump," Expand Field to 750 Swimmers
- Mayor Brandon Johnson and Chicago Public Schools Extend Chicago Connected Program for 2026–27 School Year
- Hardwood Flooring vs Carpet Comparison: Premier Custom Hardwood Flooring Releases Ultimate Buyer's Guide
- The Kryder Law Group, LLC Recovers $1,350,000 in Two Motorcycle Accident Settlements
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89